BioPlan Associates, Inc.: Smart & Aggressive Tactical Marketing Decisions since 1989
What's New
China Biopharma Newsletter
India Biopharma Newsletter
Biotherapeutics in China Database
Articles and Reports
Just Released! Biopharmaceuticals in the US and European Markets, 6th Edition
Register for White Papers

Commercializing Biotechnology and Life Sciences


enlarge cover

Society for Industrial Microlbiology logo

Advances in Biopharmaceutical Technology in India

A Society for Industrial Microbiology and BioPlan Associates co-publication

BioPlan Associates in India can provide you the most up-to-date news and perspective on events and trends in this rapidly-changing biopharmaceutical industry. Whether you require basic information, or extensive support in partnering with the right companies in India, BioPlan will work with you to meet your needs.

Available January 2008:

ADVANCES IN BIOPHARMACEUTICAL TECHNOLOGY IN INDIA
Publication date: January 2008
BioPlan Associates, Inc. and Society for Industrial Microbiology

ISBN: 978-1-934106-07-5

Download Table of Contents [PDF 758k]

Download Brochure [PDF 221k]

ORDER NOW

 

Abstracts

 
PART ONE: INTRODUCTION
1
Introduction: Biotechnology in India, Dr. P. K. Ghosh President-Biotechnology Cadila Pharmaceuticals Ltd


 
PART TWO: THE STATE OF INDIA BIPHARMACEUTICAL INDUSTRY

2
A Window into India’s Biopharmaceutical Sector, N. Kulkarni, Biospectrum Asia
3
Indian Biopharmaceutical System and Policies, Yennapu Madhavi, Ph. D, Scientist, National Institute of Science Technology and Development Studies
4
Government Support for Biotech and Biopharmaceutical Industry, Dr. B. M. Gandhi, CEO, Neo BioMed Services
5
Biopharmaceutical Products in India, Dr. Scott Wheelwight, Dr. Hazel Aranha, President, Strategic Manufacturing Worldwide, Inc.
6 Biogeneric Manufacturing in India, Dr. Ashesh Kumar, General Manager M J Biopharm Pvt. Ltd.
7 Biopharmaceutical Market Situation, Dr. Merlin Goldman President, Magnetical, U.K.
8 Contract Research Industry in India, Dr. Umakanta Sahoo & Dr. Faiz Kermani, Managing Director, Chiltern International Private Ltd.
9 Regulatory Landscape for Clinical Trials in India, Dr. Romi Singh, Executive Director, Global Regulatory Affairs, Amgen Inc.
10 Life Sciences Education in India, Dr. Dipti Sawant Dr. Umakanta Sahoo, Chiltern International Private Ltd.


 
PART THREE: SCIENTIFIC ISSUES

11
Vaccines Industry in India, Dr. PS Kulkarni Dr. SS Jadhav, Deputy Medical Director /Executive Director, Serum Institute of India Ltd.
12
Development of plasma-derived biopharmaceuticals in India: issues and opportunities, Dr. John Curling, President, John Curling, Consulting AB
13
Bioprocess Technology in India, Dr. David Mousdale, Managing Director Beocarta Ltd., U.K.
14
Potential Applications of Recent Advances in Immunology to Develop Novel Therapeutic Products in India, Dr. Kumar Shah, President, Endocrine Technology, LLC
15 Early Stage Key R&D for Successful Developmetn of Protein Products, K. Madduri, Ph.D Dow AgroSciences LLC
16 Understanding Ayurveda Medicine, Dr. Sampada Mahajan, Chiltern International Private Ltd.


 
PART FOUR: BIOBUSINESS IN INDIA

17
Biopharmaceutical Outsourcing: A comparative Overview of the Landscape in India and China, Minna Damani Editor, CanBiotch
18
Biopharmaceutical Research Collaboration between Western and Indian Life Science Organizations, Dr. Steve Ferguson, Director, Dr. Uri Reichman, Dr. Bharat Khurana, NIH Office of Technology Transfer
19
Outsourcing R&D to India, Sajai Singh, Probir Roy J. Sagar Associates
20
Venture Capital Financing, Sajai Singh Probir Roy Chodhur J. Sagar Associates

India Briefs

1
Pre Clinical and Clinical Trial in India, V.K.Srinivas, Ph.D, General Manager, R&D, Bharat Biotech International Limited
2
Technology Transfer: Impact and Importance for Indian Biotechnology Growth, Susan Kling Finston, Founder and Principal, Finston Consulting, LLC
3
Outsourcing Biopharma R&D to India, Jim Schnabel, Senior Research Associate, BioPlan Associates, Inc.
 


 

back to top